Company overview
Basic information
Company name
Arčiau gamtos, MB
Company code
306670291
Registered address
Klaipėdos r. sav., Sendvario sen., Klemiškės II k., Laukupės g. 10, LT-91287
Registration date
2024-01-29
Company age: 2 y. 8 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Retail sale of pharmaceutical products
Ownership form
Private without foreign capital
MB Arčiau gamtos
Company code: 306670291
Address: Klaipėdos r. sav., Sendvario sen., Klemiškės II k., Laukupės g. 10, LT-91287
Download a detailed company report
Make confident decisions with all the information about Arčiau gamtos, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
Arciau gamtos, MB (company code 306670291) is an operational private small partnership registered on 29 January 2024. The company operates in the national private non-financial companies sector and is classified as a micro-sized business. Its governance is described as CEO only, and its ownership is private, with more than 50% of the authorised capital held by Lithuanian natural and legal persons and no foreign investor capital. The company is located in Klemiškes II village, Sendvario eldership, Klaipeda district municipality, Klaipeda County.
The company’s activity is classified under EVRK code G.47.73.00, retail sale of pharmaceutical products. In financial year 2025, it generated EUR 43.9K in revenue and EUR 17.8K in net profit, with profit before tax of EUR 19.0K and a profit margin of 40.7%. At the end of 2025, equity stood at EUR 17.8K, total assets at EUR 21.9K, and liabilities at EUR 4.0K. Short-term assets accounted for EUR 21.2K, while long-term assets were EUR 617.
The company’s activity is classified under EVRK code G.47.73.00, retail sale of pharmaceutical products. In financial year 2025, it generated EUR 43.9K in revenue and EUR 17.8K in net profit, with profit before tax of EUR 19.0K and a profit margin of 40.7%. At the end of 2025, equity stood at EUR 17.8K, total assets at EUR 21.9K, and liabilities at EUR 4.0K. Short-term assets accounted for EUR 21.2K, while long-term assets were EUR 617.